Suppr超能文献

相似文献

2
Study of aqueous cytokines in patients with different patterns of diabetic macular edema based on optical coherence tomography.
Int Ophthalmol. 2018 Feb;38(1):241-249. doi: 10.1007/s10792-017-0453-2. Epub 2017 Feb 3.
3
Aqueous Humor Cytokine Levels and Anatomic Response to Intravitreal Ranibizumab in Diabetic Macular Edema.
JAMA Ophthalmol. 2018 Apr 1;136(4):382-388. doi: 10.1001/jamaophthalmol.2018.0179.
4
Anti-VEGF Therapy Reduces Inflammation in Diabetic Macular Edema.
Ophthalmic Res. 2021;64(1):43-49. doi: 10.1159/000508953. Epub 2020 May 26.
5
Effects of soluble CD14 and cytokine levels on diabetic macular edema and visual acuity.
Retina. 2013 May;33(5):1020-5. doi: 10.1097/IAE.0b013e31826f0688.
6
Effects of ranibizumab on growth factors and mediators of inflammation in the aqueous humor of patients with diabetic macular edema.
Graefes Arch Clin Exp Ophthalmol. 2021 Sep;259(9):2597-2603. doi: 10.1007/s00417-021-05154-8. Epub 2021 Mar 26.
7
Aqueous Humor Cytokines and Long-Term Response to Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema.
Am J Ophthalmol. 2019 Oct;206:176-183. doi: 10.1016/j.ajo.2019.04.002. Epub 2019 Apr 6.
8
Involvement of Cytokines in the Pathogenesis of Diabetic Macular Edema.
Int J Mol Sci. 2021 Mar 26;22(7):3427. doi: 10.3390/ijms22073427.
9
Novel therapeutic targets in diabetic macular edema: Beyond VEGF.
Vision Res. 2017 Oct;139:221-227. doi: 10.1016/j.visres.2017.06.015. Epub 2017 Oct 16.
10
Current intravitreal pharmacologic therapies for diabetic macular edema.
Postgrad Med. 2015 Aug;127(6):640-53. doi: 10.1080/00325481.2015.1052523. Epub 2015 Jun 3.

引用本文的文献

1
Association of serum proinflammatory factors with clinical response to ranibizumab for diabetic macular edema.
Exp Ther Med. 2025 Jul 21;30(3):177. doi: 10.3892/etm.2025.12927. eCollection 2025 Sep.
3
Rationale of Basic and Cellular Mechanisms Considered in Updating the Staging System for Diabetic Retinal Disease.
Ophthalmol Sci. 2024 Mar 27;4(5):100521. doi: 10.1016/j.xops.2024.100521. eCollection 2024 Sep-Oct.
4
Beyond VEGF: Angiopoietin-Tie Signaling Pathway in Diabetic Retinopathy.
J Clin Med. 2024 May 9;13(10):2778. doi: 10.3390/jcm13102778.
5
Aflibercept Off-Target Effects in Diabetic Macular Edema: An In Silico Modeling Approach.
Int J Mol Sci. 2024 Mar 23;25(7):3621. doi: 10.3390/ijms25073621.
6
Real-World Experience With Brolucizumab 6 mg for Diabetic Macular Edema.
Cureus. 2024 Jan 12;16(1):e52176. doi: 10.7759/cureus.52176. eCollection 2024 Jan.
7
8
Aqueous Humor Cytokines in Non-Proliferative Diabetic Retinopathy.
Medicina (Kaunas). 2022 Jul 8;58(7):909. doi: 10.3390/medicina58070909.
9
The Role of Intravitreal Corticosteroids in the Treatment of DME: Predictive OCT Biomarkers.
Int J Mol Sci. 2022 Jul 8;23(14):7585. doi: 10.3390/ijms23147585.

本文引用的文献

2
Diabetic retinopathy.
N Engl J Med. 2012 Mar 29;366(13):1227-39. doi: 10.1056/NEJMra1005073.
3
Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.
Ophthalmology. 2012 Apr;119(4):789-801. doi: 10.1016/j.ophtha.2011.12.039. Epub 2012 Feb 11.
4
Changes in aqueous concentrations of various cytokines after intravitreal triamcinolone versus bevacizumab for diabetic macular edema.
Am J Ophthalmol. 2011 Oct;152(4):686-94. doi: 10.1016/j.ajo.2011.03.033. Epub 2011 Jul 22.
5
Inflammatory and angiogenic factors in the aqueous humor and the relationship to diabetic retinopathy.
Curr Eye Res. 2010 Dec;35(12):1116-27. doi: 10.3109/02713683.2010.510257.
7
Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study.
Ophthalmology. 2010 Nov;117(11):2146-51. doi: 10.1016/j.ophtha.2010.08.016. Epub 2010 Sep 19.
10
Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.
Ophthalmology. 2010 Jun;117(6):1064-1077.e35. doi: 10.1016/j.ophtha.2010.02.031. Epub 2010 Apr 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验